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uPAR’s signaling two step
T
he uPA receptor (uPAR) is a loner. Jutting from the plasma mem-
brane, it has no apparent connection to the cell interior. But, as 
Madsen et al. demonstrate on page 927, uPAR induces cells 
to cling tightly to a surface. The behavior might recruit other receptors 
and explain how the seemingly isolated uPAR exerts its inﬂ  uence.
Stimulating uPAR galvanizes cells—they attach to a surface, 
ﬂ  atten, move, and divide. Cancer cells exploit the receptor’s power 
by cranking up its expression. But based on its structure, uPAR seems 
like a signaling dead end, and researchers had assumed that uPAR 
handed off its messages by binding to integrins.
Madsen et al. tested that idea by replacing every amino acid 
in the receptor one at a time with alanine. They found that cells 
showed the typical response to uPAR stimulation unless the alanine swap meddled with the 
receptor segments that bind to vitronectin, a protein in the extracellular matrix. Tampering with 
uPAR’s integrin-binding sites had no impact.
To show that attachment to vitronectin was sufﬁ  cient for message transmission, the researchers 
modiﬁ  ed cells to make a composite protein. One end sported the membrane-anchoring portion of uPAR, 
and the other end carried the vitronectin-recognizing stretch of an unrelated matrix-binding protein. The 
hybrid protein sparked the same effects as uPAR. Together, the results show that lateral interactions 
between integrins and uPAR aren’t essential for relaying signals to the inside of the cell.
Integrins still take part in communication, however. Cells grown on a form of vitronectin 
that lacked an integrin-binding site ignored uPAR stimulation. Madsen et al. conclude that uPAR 
signaling occurs in two steps. The receptor ﬁ   rst latches onto vitronectin, spurring the cell to 
snuggle up to the surface. This close contact then promotes liaisons between vitronectin and 
integrins, which send the messages on their way. 
Merlin casts spell on proliferation protein
T
he tactic that the protein Merlin 
uses to prevent tumors isn’t 
magical, but it is unique, as Curto 
et al. report on page 893. The protein 
locks up a growth-inducing receptor in the 
membrane so that it can’t broadcast its 
signals. The results suggest a possible way 
to combat some hard-to-treat cancers.
Like its mythological namesake, 
Merlin is powerful and mysterious. Its gene, 
NF2, goes awry in several cancers. But 
researchers didn’t know how Merlin checks 
cell proliferation. Some evidence pointed 
to an interaction with the epidermal growth 
factor receptor (EGFR), which spurs cells 
to divide. In fruit fl  ies, for example, the 
Merlin and EGFR pathways intersect.
To determine whether Merlin targets 
EGFR, the researchers compared the re-
ceptor’s activity in normal cells and cells 
lacking Merlin. As the culture dish be-
came crowded, the normal cells shut down 
EGFR signaling and stopped dividing. 
But in the Merlin-deficient group, EGFR 
remained active even as cells piled up.
Stimulated EGFR exits the surface of 
the membrane and enters the cell; many 
researchers think this step is crucial for 
signal transmission. In cells missing 
Merlin, Curto et al. found, EGFR intake 
continued even as culture density increased. 
But internalization stopped in cells that 
made Merlin, and EGFR was shunted into 
the most insoluble part of the membrane. 
That discovery indicates that, when cells 
feel crowded, Merlin incarcerates EGFR 
so that it can’t transmit further growth-
promoting messages.
As contact between cells is known to 
spur Merlin expression, the results also 
help clear up the long-standing mystery 
of how cells stop dividing when they 
touch each other, a phenomenon called 
contact inhibition.
Tumors that arise because of NF2 
defects often sprout in the spinal cord or 
brain and can be hard to remove. The work 
suggests that EGFR blockers, some of 
which are already on the market, might 
attack these growths. 
uPAR only needs to bind to vitronectin in the matrix to prompt 
cells to extend lamellipodia and ﬁ  lopodia.
Even when crowded, cells lacking Merlin 
continue to take in vesicles holding EGFR (red).